CLAR vs KEQU
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CLAR shows bearish fundamentals based on deterministic rules. Financial strength is stable (F-Score 5/9). Concerns include weak profitability or high valuation.
KEQU presents a contradictory profile where a stable Piotroski F-Score (4/9) is overshadowed by a severe collapse in earnings growth (-48.90% YoY) and a dismal earnings track record (0/3 beats). While the current price of $34.92 sits below the Graham Number ($45.43), it trades at a premium to its growth-based intrinsic value of $26.04. The combination of a 0/100 technical trend and aggressive insider selling by both the CEO and CFO suggests a lack of confidence in near-term recovery. Despite a low trailing P/E, the rising forward P/E indicates that the market expects further earnings deterioration.
Compare Another Pair
Related Comparisons
CLAR vs KEQU: Head-to-Head Comparison
This page compares Clarus Corporation (CLAR) and Kewaunee Scientific Corporation (KEQU) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.